No quarterly revenue total was found in Westin Acquisition Corp.'s SEC filings.
Westin Acquisition Corp. (WSTN) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine.
Revenue
—
Net income
$385,066
+1.1% vs prior quarter
Operating cash flow
$-42,620
+39.6% vs prior quarter
Free cash flow
—
EPS
$-0.00
Dividend per share
None
Shares outstanding
7.91M
-1.8% vs prior quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- WSTN (Nasdaq), WSTNR (Nasdaq), WSTNU (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Cayman Islands
- Headquarters
- Singapore
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2076192
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q4 FY2026 Jun 30, 2026 |
Q3 FY2026 Mar 31, 2026 |
Q2 FY2026 Dec 31, 2025 |
Q1 FY2026 Sep 30, 2025 |
|---|---|---|---|---|
| Net income | $385,066 | $380,859 | $128,860 | -$4,339 |
| Diluted EPS | — | — | — | -$0.00 |
| Operating cash flow | -$42,620 | -$70,543 | -$217,828 | — |
| Total assets | $59.2M | $58.7M | $58.3M | $460,563 |
| Total liabilities | $2.9M | $2.8M | $2.8M | $449,377 |
| Stockholders' equity | $1.9M | $4.2M | $5.1M | $11,186 |
| Cash and investments | $319,009 | $361,629 | $432,172 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Sep 29, 2026 | Jun 30, 2026 |
| 10-Q/A | Amended quarterly report | Sep 28, 2026 | Mar 31, 2026 |
| 10-Q/A | Amended quarterly report | Sep 28, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Change in control, Regulation FD disclosure
|
Jul 29, 2026 | Jul 22, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 13, 2026 | Dec 31, 2025 |
All 41 Westin Acquisition Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.